Verapamil Hydrochloride Capsule, Delayed Release Pellets
Product Images NDC 0591-2886

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 0591-2886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Verapamil Hydrochloride Structural Formula (Verapamil 01)

Chemical structure diagram of Verapamil Hydrochloride showing the molecular arrangement including two aromatic rings with methoxy groups, a nitrile group, and a hydrochloride component, as depicted in the image.*

FDA Label Image

Principal Display Panel (120 mg Capsule Bottle Label)

Label for Verapamil Hydrochloride 120 mg sustained-release capsules, displaying the drug name, strength, and dosage form. The label shows a package size of 100 capsules, marked Rx Only, with instructions about storage and dispensing. The labeler is Actavis Pharmaceuticals Inc, with manufacturing by Recro Gainesville LLC. A barcode and NDC 0591-2880-01 are included.*

FDA Label Image

Principal Display Panel (180 mg Capsule Bottle Label)

Label for Verapamil Hydrochloride 180 mg sustained-release capsules by Actavis. The label shows a capsule image half gray and half orange, marked 60274 and 180 mg. The package contains 100 capsules. The label includes storage instructions, prescribing references, and manufacturer info: Recró Gainesville LLC, distributed by Actavis Pharma, Inc.*

FDA Label Image

Principal Display Panel (240 mg Capsule Bottle Label)

Label for Verapamil Hydrochloride Sustained-Release Capsules showing a 240 mg strength, with a bottle image containing light brown capsules stamped with '0272' and '240 mg'. The label includes NDC 0591-2884-01 and indicates 100 capsules per container. Manufactured by Recro Gainesville LLC and distributed by Actavis Pharma Inc.*

FDA Label Image

Principal Display Panel (360 mg Capsule Bottle Label)

Label for Verapamil Hydrochloride 360 mg sustained-release capsules by Teva Pharmaceuticals Inc. The label indicates 100 capsules per container, prescription only. It includes storage instructions, manufacturer Recro Gainesville LLC, and distributor Actavis Pharma. Features a purple and white design with dosage strength prominently displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.